It further perturbs K-Ras PM nanoclustering and blocks K-Ras signaling and the growth of K-Ras–addicted pancreatic and NSCLC cell lines (Garrido et al., 2020). This evidence concerns the gene KRAS and non-small cell lung carcinoma.